Moderna notches small profit as it prioritizes work on cancer vaccines
International Covid-19 vaccine sales helped propel Moderna to its first profitable quarter in two years, as its return to cancer leaps forward. “I don't normally use a lot of hyperbole, but it was a great ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
